NCT05722834

Brief Summary

This research is studying whether changing an individual's behaviors may have an impact as a treatment or outcome for asthma. The purpose of this study is to implement and evaluate an asthma self-management intervention through multiple locations in the United States that is tailored to the challenges older adults face and is based on an individual behavioral theory of change. Eligible participants will be enrolled and participate for six weeks in the SOAR intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable asthma

Timeline
Completed

Started Jun 2023

Shorter than P25 for not_applicable asthma

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 1, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 10, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

June 13, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 14, 2024

Completed
17 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2024

Completed
Last Updated

July 1, 2024

Status Verified

June 1, 2024

Enrollment Period

11 months

First QC Date

February 1, 2023

Last Update Submit

June 28, 2024

Conditions

Keywords

Asthma educationSelf-RegulationRemote educationCounseling

Outcome Measures

Primary Outcomes (3)

  • The Feasibility of Intervention Measure (FIM) of the SOAR intervention for patients and providers

    A 4-item instrument to assess perceived intervention feasibility. Items are measured on a 5-point Likert scale (Completely Disagree-Completely Agree). Score is calculated mean. Higher scores indicate greater perceived feasibility.

    Day 43

  • Acceptability of Intervention Measure (AIM) of the SOAR intervention for patients and providers

    A 4-item measure of perceived intervention acceptability. Items are measured on a 5-point Likert scale (Completely Disagree-Completely Agree). Score is calculated mean. Higher scores indicate greater perceived acceptability.

    Day 43

  • Intervention Appropriateness Measure (IAM) for patients and providers

    This is a 4-item measure of perceived intervention appropriateness. Items are measured on a 5-point Likert scale (Completely Disagree-Completely Agree). Score is calculated mean. Higher scores indicate greater perceived appropriateness.

    Day 43

Secondary Outcomes (6)

  • Change in Asthma control will be determined with the Asthma Control Test (ACT)

    baseline to 6 months

  • Change in Perceived Control of Asthma Questionnaire (PCAQ)

    baseline to 6 months

  • Change in Health Care Communication Questionnaire (HCCQ)

    baseline to 6 months

  • Change in Geriatric Depression Scale - Short Form (GDS-SF-15)

    baseline to 6 months

  • Change in Mini Asthma Quality of Life Questionnaire (AQOL)

    baseline to 6 months

  • +1 more secondary outcomes

Study Arms (1)

SOAR intervention

EXPERIMENTAL

The SOAR intervention will be a remote intervention that will follow a self-regulation process in which the participant first selects a specific problem to address and researches how asthma is preventing resolution of the problem, and finally identifies and develops a plan to achieve the objective.

Behavioral: SOAR intervention

Interventions

This program intervention will be over 6 weeks and participants will have two group sessions and individual sessions, all conducted by an asthma health coach over Zoom (or phone). The two Zoom group sessions will be recorded so that all the information from the conversations will be maintained and used for research purposes. Additionally, participants will keep track of asthma symptoms and complete surveys at specified time-points (the last one at 6 months after participation). Primary care physicians will be sent emails regarding the self-management goals of their patients.

SOAR intervention

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Physician diagnosis of asthma
  • Poorly controlled asthma, as evidenced by a score ≤ 19 on the Asthma Control Test
  • Have a primary care provider willing to participate in the study by receiving email updates regarding the status of the participant

You may not qualify if:

  • Physician diagnosis of any other significant cardiopulmonary disease (including chronic obstructive pulmonary disease)
  • A greater than 20 pack-year smoking history
  • Lack of telephone access
  • Decreased cognitive capacity such that participation in the program would not be possible

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

University of Illinois-Chicago

Chicago, Illinois, 60607, United States

Location

University of Michigan

Ann Arbor, Michigan, 48109, United States

Location

University of Vermont

Burlington, Vermont, 05405, United States

Location

MeSH Terms

Conditions

AsthmaSelf-Control

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System DiseasesSocial BehaviorBehavior

Study Officials

  • Alan Baptist, MD

    University of Michigan

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: 12 participants along with the Primary care physicians will be enrolled (both will sign consents).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Internal Medicine

Study Record Dates

First Submitted

February 1, 2023

First Posted

February 10, 2023

Study Start

June 13, 2023

Primary Completion

May 14, 2024

Study Completion

May 31, 2024

Last Updated

July 1, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations